Original version

BBC World Service

BBC World Service Radio

World Service Radio

Discovery

Documentaries

Factual: Science & Nature

Factual: Science & Nature: Science & Technology

BBC World Service Online

BBC World Service Europe and the Middle East

BBC World Service schedule for American satellite radio and the Caribbean

BBC World Service Americas and the Caribbean

BBC World Service West and Central Africa Schedule

BBC World Service West and Central Africa

BBC World Service East Asia

BBC World Service South Asia

BBC World Service Australasia

BBC World Service East and Southern Africa Schedule

BBC World Service East and Southern Africa

Discovery: Problems of Developing Drugs

Magazines & Reviews

Problems of Developing Drugs

16/11/2015 GMT

BBC World Service - Discovery, Problems of Developing DrugsSearch BBC

Jim al-Khalili meets Patrick Vallance heading drug development at a pharmaceutical company

Jim al-Khalili talks to Patrick Vallance who heads up drug development at the pharmaceutical company Glaxo Smithkline about his life in science and industry.

Patrick Vallance is something of a rare breed - a game-keeper turned poacher; an academic who has moved over into industry. And not just any industry, but the pharmaceutical industry. At the time, Patrick Vallance was professor of Clinical Pharmacology and head of the Department of Medicine at University College London. A pioneer of research into some of the body’s key regulatory systems, he had also been publicly critical of big Pharma for “funding studies more helpful to marketing than to advancing clinical care”. So what made him go over to "the other side"?

His involvement with the industry was limited until one evening in 2006 when he was asked a question over a dinner, a question that would be pivotal to his life and career. 

Today, Patrick is head of research and development at GlaxoSmithKline, one of the world’s largest pharmaceutical companies with annual revenues in excess of £20 billion and nearly a 100,000 employees worldwide. Whilst GSK is no stranger to scandal, since he joined, Patrick has attempted to tackle the culture of secrecy that pervades the industry. He has since reshaped the way GSK carries out its research and has been behind several radical initiatives in global healthcare, to produce a more collaborative approach to tackling major diseases like malaria.

(Photo: Coloured pills)

Accessibility links

Programme Index

Discovery

Problems of Developing Drugs

Genres

Formats

Brand

BBC World Service

About BBC World Service